Wright Woodring E, Shay Jerry W
Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390-9039, USA.
Nat Biotechnol. 2002 Jul;20(7):682-8. doi: 10.1038/nbt0702-682.
Replicative aging is the process by which most normal human cells "count" the number of times they have divided, eventually undergoing a growth arrest termed cellular senescence. This process is dependent on the shortening of telomeres, repeated sequences at the ends of the chromosomes. The loss of telomeric sequences with each cell division eventually induces a growth arrest that has a similar phenotype to that of cells stressed by inadequate culture or other conditions. Experiments over the past several years have identified species in which replicative aging does not occur and many examples in which a failure to proliferate has been misinterpreted as replicative senescence. Insights from these studies now permit a reevaluation of much of the seemingly contradictory data concerning replicative aging. There are good theoretical reasons for believing a limited proliferative capacity contributes to declining tissue homeostasis with increasing age. Although the presence of telomere shortening provides strong circumstantial evidence that replicative aging is occurring in vivo, thus far there is only very limited direct evidence for actual physiological effects of replicative aging.
复制性衰老指的是大多数正常人类细胞“计算”其分裂次数的过程,最终会经历一种称为细胞衰老的生长停滞。这个过程依赖于端粒的缩短,端粒是染色体末端的重复序列。每次细胞分裂时端粒序列的丢失最终会诱导生长停滞,其表型与因培养条件不足或其他条件而受到应激的细胞相似。过去几年的实验已经鉴定出不存在复制性衰老的物种,以及许多将无法增殖错误地解释为复制性衰老的例子。这些研究的见解现在使得人们能够重新评估许多关于复制性衰老的看似矛盾的数据。有充分的理论依据认为,有限的增殖能力会随着年龄增长导致组织内稳态下降。虽然端粒缩短的存在提供了强有力的间接证据,表明体内正在发生复制性衰老,但迄今为止,关于复制性衰老实际生理效应的直接证据非常有限。